The pharmaceutical and vitamin markets are significantly opportunities for Novonix for their DMPG Royalty Agreements.
I personally know three people in those industries, 2 from the Pharma and 1 from the Vitamin industries, who invested significant amounts in Novonix on the back of that patent alone.
They can see the hundreds of millions in production savings the DPMG patent will save those two industries alone.
They still don’t understand the EV market.
Media Watch - NVX related, page-194
-
- There are more pages in this discussion • 14,226 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.0¢ |
Change
0.045(6.04%) |
Mkt cap ! $386.3M | |||
| Open | High | Low | Value | Volume |
| 78.5¢ | 80.0¢ | 76.5¢ | $2.643M | 3.376M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23764 | 79.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.5¢ | 122054 | 7 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| NVX (ASX) Chart |